Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
02/2013
02/06/2013CN102908483A Drug for use in palm correction implantation treatment and method for preparing same
02/06/2013CN102908478A Moist and soft plaster for relieving muscles and strengthening bones
02/06/2013CN102908476A Medicinal composition for treating rheumatoid arthritis
02/06/2013CN102908471A Method of preparing medication--dog bone and baina pills for the treatment of sciatica
02/06/2013CN102908468A Traditional Chinese medicine formula for treating lumbago
02/06/2013CN102908462A Isatis root particle and preparation method thereof
02/06/2013CN102908457A Traditional Chinese medicine for treating bony spur by using ventilago leiocarpa
02/06/2013CN102908442A Composition for treating traumatic injuries and medicinal liquor thereof
02/06/2013CN102908441A Pain relieving micro-emulsion pharmaceutical composition gel ointment and preparation method thereof
02/06/2013CN102908419A Blood circulation promoting and cold dispelling medicinal liquor and preparation method thereof
02/06/2013CN102908415A Preparation method of Bitongxiao cataplasm
02/06/2013CN102908407A Bathing product containing medicine component for preventing rheumatism ostalgia
02/06/2013CN102908401A Application of fructus piperis longi on preparation of medicine for inhibiting neuroinflammation
02/06/2013CN102908394A Chinese medicament for activating promoting blood circulation to remove blood stasis and relieving pains
02/06/2013CN102908384A Method for purifying phlomis umbrosa turcz total iridoid glycoside
02/06/2013CN102908380A Dry-type processing method of honeysuckle
02/06/2013CN102908374A Method for extracting total saponin from kalopanax septemlobus leaves
02/06/2013CN102908373A Extraction method of total eoumarins in Chinese medicament common cnidium fruit
02/06/2013CN102908372A Preparation method of concentrated Chinese thorowax root oral liquid
02/06/2013CN102908358A Compound preparation for preventing and treating proventriculitis of chicken
02/06/2013CN102908339A Tapentadol compositions
02/06/2013CN102908311A Tolfenamic acid injection and preparation method and application thereof
02/06/2013CN102908310A Meloxicam injection for treating chronic infectious arthritis of dogs and cats
02/06/2013CN102416095B Chinese medicine composition for treating amygdalitis and pharyngitis
02/06/2013CN102397264B Method for preparing sinomenine hydrochloride sustained-release tablet
02/06/2013CN102250214B Polypeptide for resisting rheumatoid arthritis and application of polypeptide in pharmacy
02/06/2013CN102178759B Traditional Chinese medicine composition for treating rheumatism and preparation method of composition
02/06/2013CN102160890B Pharmaceutical composition comprising an analgesic peptide
02/06/2013CN101732405B Common lamiophlomis extract, medicine composition containing same and quality control method
02/06/2013CN101679272B Triazolo [1, 5-a] quinolines as adenosine A3 receptor ligands
02/06/2013CN101389632B Spiroketals
02/06/2013CN101235071B Diene oleanolic acid pentacyclic triterpenes derivatives and use thereof
02/05/2013US8367664 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
02/05/2013US8367614 Rheumatoid arthritis-preventive agent for oral intake
02/05/2013US8367100 Preparation and use of sleeve and micro-encapsulated topical analgesic patch for treating pain
02/05/2013CA2511340C Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
02/05/2013CA2492273C 3, 10, and 12a substituted tetracycline compounds
02/05/2013CA2428176C Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2
01/2013
01/31/2013WO2013016178A1 N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors
01/31/2013WO2013016174A1 A crystalline form of the sodium salt of 4-tert-butyl-n-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzene sulfonamide
01/31/2013WO2013015288A1 Lipase activity inhibitor
01/31/2013WO2013014680A1 Method for treatment of pain and inflammation
01/31/2013WO2013014660A1 Indane dimers for use in the treatment of autoimmune inflammatory disease
01/31/2013WO2013014587A1 Heterocyclic amide derivatives as p2x7 receptor antagonists
01/31/2013WO2013014204A2 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
01/31/2013WO2013014038A1 3-oxo-2,3-dihydro-1h-indazole-4-carboxamide derivatives as parp-1 inhibitors
01/31/2013WO2013013609A1 Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereof
01/31/2013WO2012143416A3 7 - (3,5 - dimethyl - 4 - isoxazolyl) - 8 - (methyloxy) - 1h - imidazo [4,5 -c] quinoline derivatives
01/31/2013WO2012135812A3 Treatment for dermatological pathologies
01/31/2013WO2012037043A9 Treatment of autoimmune inflammation using mir-155
01/31/2013US20130030049 Methods of treating dermatological disorders or conditions
01/31/2013US20130030047 Fatty Acid Derivatives of Catechins and Methods of Their use
01/31/2013US20130030038 Dermatological, Pharmaceutical Composition Suitable for Oligonucleotides
01/31/2013US20130030032 Ketorolac tromethamine compositions for treating or preventing ocular pain
01/31/2013US20130030022 Compounds Which Selectively Modulate The CB2 Receptor
01/31/2013US20130030020 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
01/31/2013US20130030014 N-(IMIDAZOLIDIN-2-YLIDENE)-HETEROCYCLOPENTA[b]PYRIDINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS
01/31/2013US20130030013 Pharmaceutical preparation comprising phenylalanine derivative
01/31/2013US20130030008 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
01/31/2013US20130030006 Agent for preventing or treating diseases accompanied by urinary pain
01/31/2013US20130030000 Pharmaceutical compositions for the treatment of pain and other indications
01/31/2013US20130029999 Myosin light chain kinase inhibitor compounds, compositions and related methods of use
01/31/2013US20130029996 Special composition for the use thereof as a drug
01/31/2013US20130029995 Substituted Bicyclic Aromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
01/31/2013US20130029991 New Phenylsulfamoyl Benzamide Derivatives as Bradykinin Antagonists
01/31/2013US20130029990 Pyrazole p38 map kinase inhibitors
01/31/2013US20130029985 Novel Compounds
01/31/2013US20130029984 Heterocyclic compounds and uses thereof
01/31/2013US20130029982 Heterocyclic compounds and uses thereof
01/31/2013US20130029978 Novel aryl urea derivative
01/31/2013US20130029977 Fused substituted aminopyrrolidine derivative
01/31/2013US20130029971 Cxcr3 receptor antagonists
01/31/2013US20130029970 CB Receptor Agonists
01/31/2013US20130029968 Indazoles
01/31/2013US20130029963 1,2,4-triazine-4-amine derivatives
01/31/2013US20130029962 Substituted Heteroaromatic Pyrazole-Containing Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
01/31/2013US20130029961 Substituted Heterocyclic Aza Compounds
01/31/2013US20130029949 Substituted Quinolines and Their Use As Medicaments
01/31/2013US20130029948 Heterocyclic autotaxin inhibitors and uses thereof
01/31/2013US20130029944 Inhibitors of protein kinases
01/31/2013US20130029924 Glycosylated valproic acid analogs and uses thereof
01/31/2013US20130029922 Formulations from natural products, turmeric, paclitaxel, and aspirin
01/31/2013US20130029921 Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
01/31/2013US20130029902 Cxc chemokine receptor 4 (cxcr4) antagonistic polypeptide
01/31/2013US20130028997 Compositions, Products, Therapeutic Uses and Procedures for the Production and/or Crystallization of Extracts of Encelia Canescens LAM (Coronilla De Fraile)
01/31/2013US20130028992 Herbal-Based Solution for Treating Symptoms of Nasal Conditions
01/31/2013US20130028985 Composition and method for treating migraines
01/31/2013US20130028984 Natural tissue scaffolds as tissue fillers
01/31/2013US20130028982 Ameliorating or therapeutic agent for chronic prostatitis, interstitial cystitis and/or urination disorders
01/31/2013US20130028977 Pharmaceutical powder composition for inhalation
01/31/2013US20130028968 Compositions and methods to relieve chronic diseases symptoms
01/31/2013US20130028955 Sustained release oral matrix and methods of making thereof
01/31/2013US20130028953 Transdermal Delivery Systems for Sufentanil
01/31/2013US20130028947 Pharmaceutical composition for topical application
01/31/2013US20130028937 Co-crystals of venlafaxine and celecoxib
01/31/2013US20130028923 Kdr peptides and vaccines comprising the same
01/31/2013US20130028916 Antagonist anti-il-7 receptor antibodies and methods
01/31/2013US20130028910 Hmg1 antibody for treating inflammatory conditions
01/31/2013US20130028907 Stable Antibody Containing Compositions
01/31/2013US20130028901 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof